First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.49 USD 6.9%
Updated: Mar 29, 2024

ADC Therapeutics SA
Total Liabilities & Equity

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
|

ADC Therapeutics SA
Total Liabilities & Equity Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Total Liabilities & Equity
$354.8m
CAGR 3-Years
-12%
CAGR 5-Years
19%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Total Liabilities & Equity
CHf182.8m
CAGR 3-Years
-9%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Total Liabilities & Equity
$2.2B
CAGR 3-Years
7%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Total Liabilities & Equity
CHf173.3m
CAGR 3-Years
-9%
CAGR 5-Years
-9%
CAGR 10-Years
-5%
Idorsia Ltd
SIX:IDIA
Total Liabilities & Equity
CHf904.2m
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Total Liabilities & Equity
CHf82.9m
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Total Liabilities & Equity?
Total Liabilities & Equity
354.8m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Total Liabilities & Equity amounts to 354.8m USD.

What is ADC Therapeutics SA's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
19%

Over the last year, the Total Liabilities & Equity growth was -33%. The average annual Total Liabilities & Equity growth rates for ADC Therapeutics SA have been -12% over the past three years , 19% over the past five years .